Streetbeat News

Price Targets

CFB

CrossFirst Bankshares (NASDAQ:CFB) has received mixed analyst ratings over the past three months, with a recent positive shift in the average 12-month price target to $16.75, up 8.06% from the previous target of $15.50. Analysts from Stephens & Co., Raymond James, and Keefe, Bruyette & Woods have provided ratings ranging from 'Equal-Weight' to 'Outperform' with price targets between $16.00 and $18.00. CrossFirst Bankshares has shown positive revenue growth, a high net margin, and strong ROE and ROA, with a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 12:00 pm

PD

PagerDuty (NYSE:PD) has received mixed analyst ratings over the past three months, with an average 12-month price target of $28.8, down from the previous $31.00. The company's financial performance shows strong revenue growth but below-average profitability and efficiency metrics, with a high debt-to-equity ratio. Analysts have recently adjusted their ratings and price targets, reflecting changes in market dynamics and company performance.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 12:00 pm

BRLT

TD Cowen analyst Oliver Chen has downgraded Brilliant Earth Group (BRLT) from Outperform to Market Perform and reduced the price target from $3.5 to $3.4.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:43 am

BIIB

UBS analyst Colin Bristow downgraded Biogen (NASDAQ:BIIB) from Buy to Neutral and set a price target of $276.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:40 am

TLYS

B. Riley Securities analyst Jeff Van Sinderen has downgraded Tilly's (NYSE:TLYS) from Buy to Neutral and reduced the price target from $10.50 to $8.75.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:38 am

CFB

Stephens & Co. analyst Matt Olney upgraded CrossFirst Bankshares (NASDAQ:CFB) from Equal-Weight to Overweight and increased the price target from $16 to $18.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:36 am

HBCP

Piper Sandler analyst Graham Dick has downgraded Home Bancorp (NASDAQ:HBCP) from Overweight to Neutral, while also raising the price target from $40 to $43. This reflects a more cautious stance on the stock's future performance, despite the slight increase in the price target.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:36 am

VRTX

Canaccord Genuity analyst Whitney Ijem has downgraded Vertex Pharmaceuticals (VRTX) from Hold to Sell, despite raising the price target from $332 to $379.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:23 am

PD

Morgan Stanley analyst Sanjit Singh has downgraded PagerDuty (NYSE:PD) from Overweight to Equal-Weight and set a price target of $30. This change reflects a revised outlook on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:20 am

DXC

JP Morgan analyst Tien-Tsin Huang has downgraded DXC Technology (NYSE:DXC) from Neutral to Underweight and reduced the price target from $27 to $24.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 11:19 am